Newest Zofran Birth Defect Lawsuit Filings Claim Anti-Nausea Drug Caused Cleft Palate, Other Defects, According to Bernstein Liebhard LLP
NEW YORK, April 10, 2015 /PRNewswire/ -- Zofran birth defect lawsuits continue to mount in courts around the country, after two families came forward with new cases last week. According to court records, a complaint filed on April 1st in the U.S. District Court, Northern District of Alabama, alleges that prenatal exposure to Zofran was responsible fora number of serious birth defects. (Case 2:15-cv-00544-JEO) A second complaint filed in the U.S. District Court, District of Montana on April 3, 2015 claims that a baby born in 1998 sustained a cleft palate due to her mother's use of Zofran in the first trimester. Among other things, the lawsuit seeks compensation for the 10 surgeries she has undergone to correct the problem. (1:15-cv-00026-SPW-CSO)
"Like other recent Zofran lawsuit filings, court records indicate that these complaints accuse GlaxoSmithKline of concealing the association between Zofran and birth defects, and of improperly marketing the medication to relieve pregnancy-related nausea and vomiting," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. In response to the growing litigation involving Zofran and birth defects, the Firm is now accepting inquiries from families whose child was allegedly born with a serious congenital abnormality due to pre-natal exposure to Zofran.
Other Zofran Lawsuits
Court records indicate that at least three other Zofran lawsuits are pending in U.S. courts, all of which claim that use of the drug in early pregnancy increases the risk that a baby will be born with a serious birth defect. These cases include a claim filed on March 6th in California's Alameda Superior Court that alleges prenatal Zofran exposure caused a little boy to suffer a heart rhythm problem called supraventricular tachycardia. (Case No. RG15761042) A case filed on February 16th in U.S. District Court, District of Massachusetts claims that Zofran caused a baby girl to be born with a number of congenital abnormalities, including heart defects. (Case 1:15-cv-10429) Two other children are alleged to have suffered Zofran-related heart defects in a case that was filed on February 12th in the U.S. District Court, Eastern District of Pennsylvania. (Case 2:15-cv-00709-PDC)
All of these lawsuits point out that Zofran, known generically as ondansetron, is only approved to prevent nausea and vomiting experienced by post-operative surgery patients, as well as cancer patients undergoing certain types of chemotherapy and radiation. The complaints further note that the U.S. Food & Drug Administration (FDA) classifies the drug in Pregnancy Category B, which indicates that it has not been well studied in pregnant women.
"One recent analysis found that ondansetron has been used to treat roughly 1 million pregnant women every year.* In light of these numbers, we would not be surprised if the Zofran litigation continues to grow in the coming months," said Mr. Liebhard.
Parents of children who were born with serious birth defects allegedly related to their mother's use of Zofran during pregnancy may be entitled to file their own claims against GlaxoSmithKline. To find out more about available legal options, please visit Bernstein Liebhard LLP's website, or call the Firm directly at (888) 340-4807.
*sciencedirect.com/science/article/pii/S0002937814008539, American Journal of Obstetrics and Gynecology, August 17, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(888) 340-4807
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (888) 340-4807. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.zofranlawsuit2015.com/
https://plus.google.com/115936073311125306742?rel=author
Logo - http://photos.prnewswire.com/prnh/20120202/MM47134LOGO
SOURCE Bernstein Liebhard LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article